Every Angle Covered.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Independence Day
Social Media
Donald Trump
Artificial Intelligence
Heatwaves
Taxes
Soccer
Stock Markets
European Union
Infrastructure
Cryptocurrency
Amazon
Published • loading... • Updated

Praluent and Repatha, Two Vital Medicines that May No Longer Be Marketed in France

Summary by Le Point.fr
INFO THE POINT. The lives of several tens of thousands of patients are threatened by the discontinuation of two effective treatments without alternatives in the field of cardiovascular diseases.

1 Articles

All
Left
Center
Right
1
Le Point.frLe Point.fr
Lean Right

Praluent and Repatha, Two Vital Medicines that May No Longer Be Marketed in France

INFO THE POINT. The lives of several tens of thousands of patients are threatened by the discontinuation of two effective treatments without alternatives in the field of cardiovascular diseases.

·Paris, France
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Le Point.fr broke the news in Paris, France on Thursday, June 26, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Paris, France icon

Paris, France

News
For You
SearchBlindspotLocal
OSZAR »